Rossmeisl reseach on dogs with brain cancers may help humans
The Roanoke Times features another good story about Neuroscience's affiliated faculty John Rossmeisl, from the Virginia-Maryland College of Veterinary Medicine, conducting clinical trials in dogs' brain tumors. Dogs can be used in trials first to determine how safely is the treatment, since the researchers and doctors who study humans and dogs works together to develop new practices for cancers.
"The trial is designed to determine a safe dosage that the FDA will allow to advance to human trials. Rossmeisl began in 2014 with the first three dogs and gave them a low dose. When they did not experience side effects, he doubled the dose for the next three dogs, and so on..."